Axiogenesis AG - Company Review
Axiogenesis AG - Company ReviewSummary
Axiogenesis AG (Axiogenesis) is a preclinical biotechnology company that specializes in development and production of stem cell-derived cell types. The company offers products such as cardiac cells, neural cells and other cell types. Its neural cell products comprise peripheral neurons, dopaminergic neurons, and astrocytes. Axiogenesis offers cardiac cells such as cardio-myocytes, ventricular cardio-myocytes, cardiac fibroblasts, and mouse IPSC and ES cardio-myocytes. The company’s services include functional cardiotox services, toxicology services, drug development services and service development and customization. It has operations in the US and Germany. Axiogenesis is headquartered in Cologne, Germany.
This comprehensive company report of Axiogenesis AG provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.